IMPDH inhibitors for antitumor therapy in tuberous sclerosis complex.

Saved in:
Bibliographic Details
Title: IMPDH inhibitors for antitumor therapy in tuberous sclerosis complex.
Authors: Valvezan AJ; Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., McNamara MC; Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Miller SK; Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Torrence ME; Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Asara JM; Division of Signal Transduction, Beth Israel Deaconess Medical Center, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Henske EP; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Manning BD; Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Source: JCI insight [JCI Insight] 2020 Apr 09; Vol. 5 (7). Date of Electronic Publication: 2020 Apr 09.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2379-3708
DOI:10.1172/jci.insight.135071